ClearPoint Neuro, Inc. (CLPT) Financial Statements
ClearPoint Neuro, Inc. (CLPT) reported trailing twelve-month revenue of $42.3M (up 25.9% year on year) and net income of -$34.6M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$31.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CLPTClearPoint Neuro, Inc.Follow CLPT — free
—
Price chart with a free account
- Market cap
- 278.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.1 | 3.9 | 3.6 | 4.6 | 5.7 | 7.4 | 7.4 | 11.2 | 12.8 | 16.3 | 20.6 | 24.0 | 31.4 | 37.0 | 42.3 | |
| Gross profit | 4.5 | 2.5 | 1.7 | 2.6 | 3.1 | 4.5 | 4.9 | 7.3 | 9.1 | 11.1 | 13.5 | 13.6 | 19.1 | 22.7 | 26.5 | |
| Research & development | 2.5 | 2.9 | 3.3 | 2.0 | 2.6 | 2.8 | 2.3 | 2.8 | 4.7 | 9.3 | 10.9 | 11.7 | 12.4 | 13.9 | 15.8 | |
| Operating income | -3.1 | -7.5 | -5.3 | -9.0 | -7.5 | -6.3 | -5.2 | -4.6 | -6.2 | -13.4 | -16.3 | -22.4 | -19.7 | -24.2 | -31.0 | |
| Pre-tax income | -5.9 | -7.1 | -4.5 | — | — | — | — | — | -6.8 | -14.4 | -16.4 | -22.1 | -18.9 | -25.5 | -34.6 | |
| Income tax | — | 0.0 | 0.0 | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | -0.0 | |
| Net income | -5.9 | -7.1 | -4.5 | -8.4 | -8.1 | -7.2 | -6.2 | -5.5 | -6.8 | -14.4 | -16.4 | -22.1 | -18.9 | -25.5 | -34.6 | |
| Diluted EPS ($) | -0.15 | -0.12 | -0.08 | -4.48 | -2.93 | -0.93 | -0.56 | -0.42 | -0.43 | -0.69 | -0.68 | -0.90 | -0.70 | -0.90 | -1.18 | |
| Diluted shares (mn) | — | — | — | — | — | — | — | — | — | — | 24.2 | 24.6 | 27.0 | 28.3 | — |
USD millions · SEC XBRL
ClearPoint Neuro, Inc. — questions
- What is ClearPoint Neuro, Inc.'s revenue?
- $42.3M over the twelve months to 2026-06-30, up 25.9% year on year, from its 10-Q and 10-K filings.
- What is ClearPoint Neuro, Inc.'s net income?
- -$34.6M over the twelve months to 2026-06-30.
- What is ClearPoint Neuro, Inc.'s free cash flow?
- -$31.3M over the twelve months to 2026-06-30.
- What are ClearPoint Neuro, Inc.'s diluted earnings per share?
- $-1.18 over the twelve months to 2026-06-30.
Every figure on this page comes from ClearPoint Neuro, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.